Acceleron Pharma Inc.

XLRN | NASDAQ | 0 Followers
$178.75 0.00% $0.00
Follow

Company Quality

Profitability Score
17/100
Solvency Score
25/100

Dividends

Dividends data currently unavailable.

Earnings

Earnings data currently unavailable.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare
Sector
Biotechnology
Industry
Mr. Habib Dable
CEO
312
Employees
Cambridge
Headquarters
US
Country

Key Metrics TTM

Valuation

Market cap.

$0

Enterprise Value

-$647M

Price to Earnings

-61.15

Price to Sales

0.00

Price to Book

11.87

Price to Cash Flow

0.00

Profitability

Return on Assets

-17.81%

Return on Equity

-25.45%

Return on Invested Capital

-19.03%

Gross Margin

100.00%

Operating Margin

-180.83%

Net Margin

-179.45%

Liquidity

Quick Ratio

14.85

Current Ratio

14.85

Cash Ratio

11.15

Inventory Turnover

0.00

Asset Turnover

0.10

Total Liabilities

N/A

Solvency

Debt to Assets

0.03

Debt to Equity

N/A

Interest Coverage

0.00

Equity Ratio

N/A

Long-term Debt to Cap.

0.00

Altman Z-Score

N/A

Performance

Performance data currently unavailable.

Earnings Waterfall

Earnings data currently unavailable.

Debt level and coverage

Debt level and coverage data currently unavailable.

Earnings

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
visibility_off
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores
visibility_off

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

We use cookies to improve your experience on our site.
Menu StockBot
Tracker
Upgrade